Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
RSPI Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: May 30, 2024
Report Source: 2023 3rd Quarter Report
RespireRx Pharmaceuticals Inc. Stock Analysis RSPI
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company is headquartered in Glen Rock, New Jersey and currently employs 2 full-time employees. The firm is focused on treatments that address conditions affecting millions of people, but for which there are few or poor treatment options, including epilepsy, pain, attention deficit hyperactivity disorder (ADHD), recovery from SCI, certain neurological orphan diseases and obstructive sleep apnea (OSA). The firm is developing a pipeline of new and repurposed drug products based on its patent portfolios for two drug platforms: neuromodulators, which include GABAkines and AMPAkines, proprietary chemical entities that positively modulate (positive allosteric modulators or PAMs) GABAA receptors and AMPA-type glutamate receptors, respectively, and pharmaceutical cannabinoids, which include dronabinol, a synthetic compound that acts upon the nervous system’s endogenous cannabinoid receptors.
Read More RespireRx Pharmaceuticals Inc (RSPI) Chart
Key Statistics of RespireRx Pharmaceuticals Inc (RSPI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
11.30KP/E Ratio (TTM)
-52 Week Range
Market Cap
511.59KAvg. Volume
68.10KDividend Yield
-Financial Metrics & Statements of RespireRx Pharmaceuticals Inc (RSPI)
FAQ's for RespireRx Pharmaceuticals Inc (RSPI)
- According to Musaffa’s Shariah screening methodology, RespireRx Pharmaceuticals Inc (RSPI) is currently classified as NOT HALAL as of May 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RespireRx Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in RespireRx Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of RespireRx Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of RespireRx Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of RespireRx Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.